Covestor
CGON icon

Covestor’s CG Oncology CGON Stock Holding History

Covestor’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$55K Buy
770
+324
+73% +$23.8K 0.04% 684
2026
Q2 		$32K Buy
446
+132
+42% +$8.63K 0.02% 989
2026
Q1 		$21K Sell
314
-35
-10% -$1.98K 0.01% 1080
2025
Q4 		$14K Sell
349
-116
-25% -$4.8K 0.01% 1424
2025
Q3 		$19K Sell
465
-4
-0.9% -$116 0.01% 1282
2025
Q2 		$12K Buy
469
+465
+11,625% +$11.2K 0.01% 1455
2025
Q1 		$0 Hold
4
– – ﹤0.01% 2270
2024
Q4 		$0 Hold
4
– – ﹤0.01% 2278
2024
Q3 		$0 Hold
4
– – ﹤0.01% 2266
2024
Q2 		$0 Buy
+4
New +$139 ﹤0.01% 2276

Other funds holding CGON

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Covestor's CGON Position: Q3 2026 in Review

Covestor increased its CG Oncology (CGON) stake by 73% in Q3 2026, buying an estimated $23.8K and bringing the position to 770 shares worth $55K. The position accounts for 0.04% of the portfolio, ranked #684.

Covestor first reported a position in CGON in Q2 2024 and has held it in 10 quarters since. 76 funds tracked by Wall St. Rank hold CGON as of Q3 2026.

  • Covestor held 770 shares of CG Oncology worth $55K as of Q3 2026.
  • Covestor bought 324 CG Oncology shares in Q3 2026, an estimated $23.8K.
  • CG Oncology made up 0.04% of Covestor's portfolio in Q3 2026, its #684 holding.
  • Covestor first reported a position in CG Oncology in Q2 2024 and has held it in 10 quarters since.
  • 76 funds tracked by Wall St. Rank held CG Oncology as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.